BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29101772)

  • 1. Liver disease symptoms in non-alcoholic fatty liver disease and small intestinal bacterial overgrowth.
    Rafiei R; Bemanian M; Rafiei F; Bahrami M; Fooladi L; Ebrahimi G; Hemmat A; Torabi Z
    Rom J Intern Med; 2018 Jun; 56(2):85-89. PubMed ID: 29101772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.
    Fitriakusumah Y; Lesmana CRA; Bastian WP; Jasirwan COM; Hasan I; Simadibrata M; Kurniawan J; Sulaiman AS; Gani RA
    BMC Gastroenterol; 2019 Mar; 19(1):43. PubMed ID: 30894137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
    Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
    J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease.
    Fialho A; Fialho A; Thota P; McCullough AJ; Shen B
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):159-65. PubMed ID: 27308646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
    Stepanov YM; Zavhorodnia NY; Yagmur VB; Lukianenko OY; Zygalo EV
    Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can concurrent lower gastrointestinal manifestations help the timely diagnosis of small intestinal bacterial overgrowth in CVID patients?
    Baniadam L; Arshi S; Nabavi M; Yousefi A; Fallahpour M; Shokri S; Zare Mehrjerdi F; Salari F; Bemanian MH
    Eur Ann Allergy Clin Immunol; 2021 Jan; 53(1):18-22. PubMed ID: 32186350
    [No Abstract]   [Full Text] [Related]  

  • 8. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS.
    GuimarÃes VM; Santos VN; Borges PSA; DE Farias JLR; Grillo P; Parise ER
    Arq Gastroenterol; 2020; 57(4):471-476. PubMed ID: 33331479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study.
    Gkolfakis P; Tziatzios G; Leite G; Papanikolaou IS; Xirouchakis E; Panayiotides IG; Karageorgos A; Millan MJ; Mathur R; Weitsman S; Dimitriadis GD; Giamarellos-Bourboulis EJ; Pimentel M; Triantafyllou K
    Microorganisms; 2023 Mar; 11(3):. PubMed ID: 36985296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.
    Lakshmi CP; Ghoshal UC; Kumar S; Goel A; Misra A; Mohindra S; Choudhuri G
    Dig Dis Sci; 2010 Apr; 55(4):1142-8. PubMed ID: 19424796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: a retrospective study of 932 patients.
    Schatz RA; Zhang Q; Lodhia N; Shuster J; Toskes PP; Moshiree B
    World J Gastroenterol; 2015 Apr; 21(15):4574-82. PubMed ID: 25914466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease.
    Shi H; Mao L; Wang L; Quan X; Xu X; Cheng Y; Zhu S; Dai F
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e535-e539. PubMed ID: 33867442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal bacterial overgrowth in diabetic gastroenteropathy.
    Varma R; Chakraborty S; Burton DD; Bailey KR; Bharucha AE
    Neurogastroenterol Motil; 2024 Jul; 36(7):e14798. PubMed ID: 38651669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.
    Sabaté JM; Jouët P; Harnois F; Mechler C; Msika S; Grossin M; Coffin B
    Obes Surg; 2008 Apr; 18(4):371-7. PubMed ID: 18286348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal bacterial overgrowth and non-alcoholic fatty liver disease diagnosed by transient elastography and liver biopsy.
    Mikolasevic I; Delija B; Mijic A; Stevanovic T; Skenderevic N; Sosa I; Krznaric-Zrnic I; Abram M; Krznaric Z; Domislovic V; Filipec Kanizaj T; Radic-Kristo D; Cubranic A; Grubesic A; Nakov R; Skrobonja I; Stimac D; Hauser G
    Int J Clin Pract; 2021 Apr; 75(4):e13947. PubMed ID: 33406286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.
    Klaus J; Spaniol U; Adler G; Mason RA; Reinshagen M; von Tirpitz C C
    BMC Gastroenterol; 2009 Jul; 9():61. PubMed ID: 19643023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated factors of small intestinal bacterial overgrowth among systemic sclerosis patients.
    Sawadpanich K; Soison P; Chunlertrith K; Mairiang P; Sukeepaisarnjaroen W; Sangchan A; Suttichaimongkol T; Foocharoen C
    Int J Rheum Dis; 2019 Apr; 22(4):695-699. PubMed ID: 30729669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K; Klupińska G; Walecka-Kapica E; Błońska A
    Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.